Story excerpt provided by Crain’s Cleveland Business.
Written by Chuck Soder.
Athersys plans to begin a new clinical trial with the help of a grant from Innovate UK, a public organization that aims to promote innovation in England.
The Cleveland-based stem cell therapy company will receive up to 2 million British pounds (about $3 million) to start a phase 2a trial that would test whether its MultiStem therapy could help patients with acute respiratory distress syndrome.
Click here to read the complete article.
Originally published January 22, 2015.